News for Marinus Pharmaceuticals, Inc. (MRNS)

On December 31, 2024, Vanguard Group Inc made a strategic decision to reduce its holdings in Marinus Pharmaceuticals Inc (MRNS) by 206,197 shares. This transact

PR NewswireNEW YORK, Jan. 15, 2025 NEW YORK, Jan. 15, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following co

Marinus Pharmaceuticals (MRNS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

PR NewswireNEW YORK, Jan. 9, 2025 NEW YORK, Jan. 9, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following comp

NEW YORK, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations o

PR NewswireNEW YORK, Jan. 6, 2025 NEW YORK, Jan. 6, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following comp

PR NewswireNEW YORK, Jan. 3, 2025 NEW YORK, Jan. 3, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following comp

NEW YORK, Dec. 31, 2024 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations o

Immedica Pharma AB (Immedica), a leading global rare disease company, and [url="]Marinus Pharmaceuticals, Inc.[/url] (Nasdaq: MRNS), a pharmaceutical company c

**media[502762]**

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.33%

U.S. stocks traded mixed this morning, with the Dow Jones index falling around 150 points on Thursday. Following the market opening Thursday, the Dow traded do...

Marinus reports positive phase 3 seizure treatment trial results

Stocks Analysis by MarketBeat.com (Leo Miller) covering: Comstock Mining Inc, Marinus Pharmaceuticals Inc, Amprius Technologies Inc. Read MarketBeat.com (Leo Miller)'s latest article on Investing.com

Marinus Pharmaceuticals' patent upheld by PTAB

Oppenheimer sees upside for Marinus Pharmaceuticals stock ahead of key trial results

The PGIM Jennison Health Sciences Fund advanced and outperformed the index during June. Read more here.

Enthusiasm about artificial intelligence helped drive collective gains in global equities during the second quarter of 2024. Click here to read the full fund letter.

Penny stocks are defined by the Securities and Exchange Commission (SEC) as stocks that trade for less than $5 per share. They exhibit high price volatility due to their low pricing.